Security key
04280A100
ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)
CUSIP: 04280A100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 141,328,976
- Total 13F shares
- 105,716,035
- Share change
- +2,396,724
- Total reported value
- $1,671,181,802
- Put/Call ratio
- 128%
- Price per share
- $15.80
- Number of holders
- 279
- Value change
- +$44,748,514
- Number of buys
- 153
- Number of sells
- 117
Report period
Q2 2025
Institutions
279
Top holders
10
ARWR full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
ARROWHEAD PHARMACEUTICALS, INC. SEC filings
ARROWHEAD PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04280A100
Recent filing periods:
Top shareholders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13D/G
13F
|
Company |
8.3%
|
11,517,441
|
$193,377,834 | -$8,581,554 | 30 Jun 2025 | |
| STATE STREET CORP |
13D/G
13F
|
STATE STREET CORPORATION · Company |
4.6%
|
6,371,056
|
$106,970,030 | -$10,547,360 | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
14%
|
19,926,154
|
$253,859,202 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.3%
|
13,202,562
|
$168,200,640 | — | 31 Mar 2025 | |
| Slate Path Capital LP |
13F
|
Company |
3.7%
|
5,232,000
|
$66,655,680 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
3.4%
|
4,785,062
|
$60,961,689 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
2.3%
|
3,315,082
|
$42,234,145 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
2,950,312
|
$37,595,616 | — | 31 Mar 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
1.9%
|
2,669,880
|
$34,014,271 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.8%
|
2,528,982
|
$32,220,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
1,848,536
|
$23,550,350 | — | 31 Mar 2025 | |
| NORGES BANK |
13F
|
Company |
1.3%
|
1,802,584
|
$22,964,920 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
1,741,666
|
$22,188,824 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.2%
|
1,626,563
|
$20,722,414 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
1,210,813
|
$15,425,757 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.76%
|
1,072,827
|
$13,667,816 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
1,035,290
|
$13,189,595 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.7%
|
986,951
|
$12,573,756 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.59%
|
835,174
|
$10,640,117 | — | 31 Mar 2025 | |
| Western Financial Corp/CA |
13F
|
Company |
0.58%
|
820,239
|
$10,449,845 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.56%
|
798,200
|
$10,169,070 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.55%
|
776,039
|
$9,886,740 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.51%
|
723,800
|
$9,221,212 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.49%
|
690,796
|
$8,800,741 | — | 31 Mar 2025 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.45%
|
629,214
|
$8,016,186 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.45%
|
629,075
|
$8,014,416 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.4%
|
562,175
|
$7,162,110 | — | 31 Mar 2025 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
0.39%
|
550,130
|
$7,008,656 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.35%
|
487,671
|
$6,212,929 | — | 31 Mar 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.34%
|
483,253
|
$6,156,641 | — | 31 Mar 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.33%
|
459,854
|
$5,858,541 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.28%
|
399,870
|
$5,094,344 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.28%
|
395,114
|
$5,033,753 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.24%
|
345,979
|
$4,407,744 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.24%
|
337,878
|
$4,304,565 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.23%
|
327,310
|
$4,169,929 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.22%
|
314,080
|
$4,001,380 | — | 31 Mar 2025 | |
| Edgestream Partners, L.P. |
13F
|
Company |
0.22%
|
305,507
|
$3,892,159 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.2%
|
289,376
|
$3,686,650 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.2%
|
288,030
|
$3,965,223 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.2%
|
286,231
|
$3,646,583 | — | 31 Mar 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.2%
|
279,749
|
$3,564,002 | — | 31 Mar 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.2%
|
277,550
|
$3,535,987 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.18%
|
249,989
|
$3,184,860 | — | 31 Mar 2025 | |
| JOHNSON & JOHNSON |
13F
|
Company |
0.18%
|
247,598
|
$3,154,399 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.17%
|
240,175
|
$3,059,830 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.17%
|
238,328
|
$3,045,992 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.16%
|
230,138
|
$2,931,959 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.15%
|
216,900
|
$2,763,306 | — | 31 Mar 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.15%
|
213,130
|
$2,715,276 | — | 31 Mar 2025 |
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR) as of Q2 2025
As of 30 Jun 2025,
ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR) was held by
279 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,716,035 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Slate Path Capital LP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, Siren, L.L.C., and MARSHALL WACE, LLP.
This page lists
281
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
258
Q2 2025 holders
279
Holder diff
21
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.